Dysregulated TGFβ signalling has also been proposed in CARASIL, with increased fibronectin expression after experimental stroke in cultured astrocytes and in vivo associated with reactive gliosis and an impaired influx of CSF showing reversal after inhibition of TGFβ [42,43]. This evidence concerns the gene FN1 and stroke disorder.